Yahoo · Oct 9, 2026
Henry Schein appoints Emmanuel Caprais as CFO
The CFO transition is part of a recent wave of leadership changes at Henry Schein, including a new CEO.
NASDAQ · HSIC
Henry Schein, Inc.
Healthcare · Medical - Distribution
$85.03
Up+$0.53 (+0.62%)
Updated Oct 15, 2026, 12:11 AM
SID Score
5.7/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 9.35B
- P/E ratio
- 23.9
- Dividend yield
- 0.00%
- 52-week range
- $68.70 – $92.18
- Volume
- 718.38K
- Avg. volume
- 1.51M
Price performance · HSIC
HSIC price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 13, 2026
HSIC closed at $85.03 after 20 trading sessions, down 2.01% for the selected period.
- Last close
- $85.03
- Period change
- -2.01%
- Period low
- $83.66
- Period high
- $87.43
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 13, 2026 | $84.76 | $85.32 | $83.87 | $85.03 | 718.38K |
| Oct 12, 2026 | $84.16 | $84.92 | $83.89 | $84.23 | 955.26K |
| Oct 9, 2026 | $84.11 | $85.13 | $83.475 | $84.01 | 1.09M |
| Oct 8, 2026 | $79.95 | $84.66 | $79.37 | $84.63 | 2.68M |
| Oct 7, 2026 | $84.79 | $85.635 | $83.56 | $83.66 | 1.31M |
| Oct 6, 2026 | $84.78 | $86.40 | $84.31 | $84.84 | 1.42M |
| Oct 5, 2026 | $85.48 | $85.51 | $83.42 | $84.23 | 1.9M |
| Oct 2, 2026 | $85.18 | $85.56 | $83.45 | $84.88 | 1.13M |
| Oct 1, 2026 | $83.96 | $85.28 | $83.30 | $84.93 | 1.03M |
| Sep 30, 2026 | $84.98 | $85.33 | $83.855 | $83.97 | 883.51K |
| Sep 29, 2026 | $85.51 | $85.86 | $84.39 | $84.97 | 978.77K |
| Sep 28, 2026 | $85.88 | $86.78 | $85.37 | $85.99 | 984.29K |
| Sep 25, 2026 | $85.53 | $86.58 | $85.43 | $86.37 | 1.2M |
| Sep 24, 2026 | $84.50 | $85.92 | $84.375 | $85.53 | 1.38M |
| Sep 23, 2026 | $86.89 | $87.98 | $84.80 | $85.05 | 1.12M |
| Sep 22, 2026 | $85.93 | $87.64 | $85.58 | $87.43 | 1.07M |
| Sep 21, 2026 | $85.25 | $85.80 | $84.40 | $85.20 | 1.35M |
| Sep 18, 2026 | $84.84 | $85.96 | $84.41 | $84.84 | 2.22M |
| Sep 17, 2026 | $87.01 | $87.10 | $84.15 | $85.04 | 1.8M |
| Sep 16, 2026 | $87.52 | $88.32 | $86.44 | $86.77 | 1.02M |
Latest HSIC news
The latest Smart Investors Daily articles mentioning HSIC.
Stock researchCompany · Overview
Company
Market Activity
Research & News
HSIC research
Overview
Company profile and research snapshot.
Company profile
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $82.50
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 19, 2026 | BTIG | Buy | — |
| Aug 6, 2026 | Barclays | Overweight | — |
| Aug 5, 2026 | Citigroup | Buy | — |
| Aug 5, 2026 | UBS | Neutral | — |
| Aug 5, 2026 | BTIG | Buy | — |
News briefing
No generated briefing is available yet.
Yahoo · Oct 8, 2026
Henry Schein Announces Chief Financial Officer Leadership Transition
MELVILLE, N.Y., October 08, 2026--Henry Schein, Inc. (Nasdaq: HSIC) announced today that Emmanuel Caprais, former Senior Vice President and Chief Financial Officer of ITT, Inc. (NYSE: ITT), has been named the Company’s Senior Vice President and Chief Financial Officer effective November 4, 2026. Mr. Caprais will join the Henry Schein Leadership Team (HSLT) and report to Frederick M. Lowery, Chief Executive Officer of Henry Schein. To support a structured transition, Mr. Caprais will initially se
Yahoo · Oct 6, 2026
Should Value Investors Buy Henry Schein (HSIC) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
SeekingAlpha · Sep 30, 2026
Cardinal Health: I'm Still Buying After Checking The Numbers
Cardinal Health remains a Buy, driven by robust FY2026 results, strong cash flow, and credible FY2027 guidance. Read more on CAH stock here.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
